These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6791202

  • 1. Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
    Pickar D, Cohen RM, Jimerson DC, Murphy DL.
    Psychopharmacology (Berl); 1981; 74(1):4-7. PubMed ID: 6791202
    [Abstract] [Full Text] [Related]

  • 2. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
    Pickar D, Cohen RM, Jimerson DC, Lake CR, Murphy DL.
    Psychopharmacology (Berl); 1981; 74(1):8-12. PubMed ID: 6791210
    [Abstract] [Full Text] [Related]

  • 3. Tyramine pressor sensitivity changes during deprenyl treatment.
    Sunderland T, Mueller EA, Cohen RM, Jimerson DC, Pickar D, Murphy DL.
    Psychopharmacology (Berl); 1985; 86(4):432-7. PubMed ID: 3929314
    [Abstract] [Full Text] [Related]

  • 4. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
    Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T.
    J Neural Transm Suppl; 1998; 52():39-48. PubMed ID: 9564606
    [Abstract] [Full Text] [Related]

  • 5. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L, Bunag RD.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
    [Abstract] [Full Text] [Related]

  • 6. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M, Gorodetsky E, Wang RH, Gross A, Weinreb O, Youdim MB.
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [Abstract] [Full Text] [Related]

  • 7. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A.
    Acta Physiol Hung; 1990 Nov; 75(4):321-36. PubMed ID: 2127505
    [Abstract] [Full Text] [Related]

  • 8. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B, Greeff K, Tawfik H.
    Arzneimittelforschung; 1982 Nov; 32(3):201-7. PubMed ID: 6805481
    [Abstract] [Full Text] [Related]

  • 9. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():81-3. PubMed ID: 2248084
    [Abstract] [Full Text] [Related]

  • 10. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
    Finberg JP, Youdim MB.
    Br J Pharmacol; 1985 Jun; 85(2):541-6. PubMed ID: 3928010
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

  • 12. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
    Murphy DL, Tamarkin L, Sunderland T, Garrick NA, Cohen RM.
    Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid.
    Humphrey SJ, Curry JT, Turman CN, Stryd RP.
    J Cardiovasc Pharmacol; 2001 May; 37(5):548-63. PubMed ID: 11336106
    [Abstract] [Full Text] [Related]

  • 14. REM sleep suppression induced by selective monoamine oxidase inhibitors.
    Cohen RM, Pickar D, Garnett D, Lipper S, Gillin JC, Murphy DL.
    Psychopharmacology (Berl); 1982 May; 78(2):137-40. PubMed ID: 6817370
    [Abstract] [Full Text] [Related]

  • 15. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 May; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 17. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW, Maguire KP, Davies BM.
    Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.
    Cohen RM, Campbell IC, Yamaguchi I, Pickar D, Kopin IJ, Murphy DL.
    Eur J Pharmacol; 1982 May 07; 80(1):155-60. PubMed ID: 6284529
    [Abstract] [Full Text] [Related]

  • 19. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB.
    J Neurochem; 1990 Feb 07; 54(2):411-4. PubMed ID: 2299343
    [Abstract] [Full Text] [Related]

  • 20. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF.
    Vopr Med Khim; 1997 Feb 07; 43(6):494-503. PubMed ID: 9503566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.